期刊文献+

海洋抗结核分枝杆菌活性物质研究近况

Research Progress on Marine Natural Products with Antimycobacterial Activity
下载PDF
导出
摘要 近年来由于结核杆菌多重耐药菌株及人体免疫缺陷病毒双重感染的出现,使结核病的发病率和死亡率呈上升趋势,开发新的抗结核药物具有重要的社会意义和经济意义。海洋由于其独特的环境,造就了种类繁多、结构新颖多样的生物活性物质,为抗结核病的药物开发提供了广泛的前景。本综述以近年报道的抗结核分枝杆菌活性物质,包括肽类化合物,生物碱类化合物,萜类化合物等为例。简要介绍海洋活性物质的研究近况。 Drug-resistant tuberculosis and Human immunodeficiency viruses infection have increased the incidence of tuberculosis. The oceans, with their unique and wide range of biodiversity, produce unusual metabolites and emerge as a good candidate of new anti-tuberculosis agents. Marine natural products that have been reported to exhibit anti-mycobacterial activity recently, include peptides, alkaloids, terpenes and so on. This review summarized the research progress on the marine bionative compounds with anti-mycobacterial activity.
出处 《抗感染药学》 2009年第1期1-4,共4页 Anti-infection Pharmacy
基金 国家自然科学基金项目(No.20772070)
关键词 海洋 活性物质 结核分枝杆菌 ocean bionative compounds Mycobacterium tuberculosis
  • 相关文献

参考文献15

  • 1Corbett EL,Watt CJ,Walker N,et al.The growing burden of tuberculosis:global trends and interactions with the HIV epidemic[J].Arch intern Med,2003,163:1009-1021.
  • 2Khalid A,Sayed El,Bartyzel P,et al.Marine Natural Products as Antituberlosis Agents[J].Tetrahedron,2000,56:949-953.
  • 3Muller D,Krick A,Keluraus S,et al.Bruosvicamides A-C:sponge related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatasc inhibitory activity[J].J Med Chem,2006,10:49(16):4871-4878.
  • 4Suntomchashwej S,Suwanborirux K,Koga K,et al.the first(7R)-lyngbic acid that connects to a new tripeptidebackbone from the Thai sea hare Bursatella leachii[J].Isobe M Chem Asian J,2007,8:(1):114-122.
  • 5Alejandro M.S,Mayer,Abimael D,et al.Marine pharmacology in 2003:Marine compounds with anthelmintic antibacterial,anticoagulant,antifungal,anti-inflammatory,antimalarial,antiplatelet,antiprotozoal,antituberculosis,and antiviral activities;affecting the cardio-vascular,immune and nervous systems,and other miscellaneous mechanisms of action[J].Comparative Biochemistry and PhysiologyPart C,2007,145:553-581.
  • 6Copp BR,Pearee AN.Natural product growth inhibitors of Mycobacterium uberculosis[J].Nat Prod Rep,2007,24(2):278-297.
  • 7Alejandro M.S.Mayer,Mark T,et al.Hamann.Marine pharma cology in 2001-2002:Marine compounds with anthelmintic,anti-bacterial,anti-coagulant,anti-diabetic,anti-fungal,anti-inflammatory,antimalarial,antiplatelet,antiprotozoal,anti-tuberculosis,and anti-viral activities; affecting the cardiovascular,immune and nervoussystems and other miscellaneous mechanisms of action[J].Comparative Biochemistry and Physiology Part C,2005,140:265-286.
  • 8Hammond NL,Yousaf M,Peng J,et al.Chemical transformation and biological studies of marine sesquiterpene(S)-(+)-cureuphenol and its analogs[J].Biochim Biophys Acta,2007,24:737-723.
  • 9Peng J,Kasanah N,Stanley CE,et al.Microbial metabolism studies of cyanthiwigin B and synergetic antibiotic effects[J].J Nat Prod,2006,69(5):727-730.
  • 10Gul W,Hammond NL,Yousaf M,et al.Chemical transformation and biological studies of marine scsquiterpene (S)-(+)-curcuphenol and its analogs[J].Biochira Biophy Acta,2007,1770(11):1513-1519.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部